UNSPSC 51111603: Floxuridine

This classification denotes a pyrimidine antagonist with the molecular formula C9H11FN2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 039LU44I5M, chemically known as uridine, 2-deoxy-5-fluoro- but generally known as floxuridine, which bears US NIH Compound Identifier 3363. European Medicines Agency schedules Floxuridine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07659MIG. The term FLOXURIDINE is an International Non-Proprietary Name.

UNSPSC 51111603 Floxuridine is a Commodity code for a chemotherapy agent used in cancer treatment regimens, but the source provides no recent state and local procurement opportunities under this code.

State and local governments do not commonly source chemotherapy drugs directly; procurement typically flows through state Medicaid agencies, hospital systems, and pharmacy benefit managers operating under federal and state drug formulary frameworks. Without documented recent solicitations, activity under this code cannot be characterized by issuing body, geographic spread, or representative opportunity type. If your firm has identified floxuridine demand within a specific state health system or Medicaid program, verify the actual UNSPSC coding used in that jurisdiction's procurement systems, as pharmaceutical commodities are frequently miscoded or handled through standing national contracts rather than individual state and local RFPs or ITBs.